{"ticker": {"uuid": "1ec8fcd7-8184-4389-9dd2-15b168369581", "symbol": "MOH", "name": "Motor Oil (Hellas) Corinth Refineries S.A.", "exchange": "ATH", "country": "GR", "sector": "Energy", "industry": "Oil & Gas Refining & Marketing"}, "articles": [{"title": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong", "summary": "Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind", "url": "https://finance.yahoo.com/healthcare/articles/cytk-q2-earnings-top-estimates-182200106.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:22:00+00:00", "published_display": "07 Aug 2026 18:22", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.061, "duplicate_count": 1, "topics": ["Biotech", "Clinical Trials", "Earnings", "Fda Approval", "Fourth Quarter", "Pharma"]}, {"title": "Bittium Oyj (HLSE:BITTI) Earnings Reset The Valuation Debate", "summary": "Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. How Bittium Oyj's Latest Earnings Shape the Investment Picture Bittium Oyj (HLSE:BITTI) reported half year 2026 sales of \u20ac57.9 million and net income of \u20ac7.5 million, compared with \u20ac42.3 million and \u20ac1.5 million a year earlier, which sharpened investor focus on the stock. Those figures, together with basic earnings per share from continuing operations of \u20ac0.211 compared with \u20ac0.043 a year ago, provide fresh data to reassess ", "url": "https://finance.yahoo.com/markets/stocks/articles/bittium-oyj-hlse-bitti-earnings-181044517.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:10:44+00:00", "published_display": "07 Aug 2026 18:10", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.099, "duplicate_count": 1, "topics": ["Balance Sheet", "Defense", "Earnings", "Earnings Growth", "Earnings Per Share", "Net Income"]}], "by_tier": {"direct": [{"title": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong", "summary": "Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind", "url": "https://finance.yahoo.com/healthcare/articles/cytk-q2-earnings-top-estimates-182200106.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:22:00+00:00", "published_display": "07 Aug 2026 18:22", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.061, "duplicate_count": 1, "topics": ["Biotech", "Clinical Trials", "Earnings", "Fda Approval", "Fourth Quarter", "Pharma"]}, {"title": "Bittium Oyj (HLSE:BITTI) Earnings Reset The Valuation Debate", "summary": "Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. How Bittium Oyj's Latest Earnings Shape the Investment Picture Bittium Oyj (HLSE:BITTI) reported half year 2026 sales of \u20ac57.9 million and net income of \u20ac7.5 million, compared with \u20ac42.3 million and \u20ac1.5 million a year earlier, which sharpened investor focus on the stock. Those figures, together with basic earnings per share from continuing operations of \u20ac0.211 compared with \u20ac0.043 a year ago, provide fresh data to reassess ", "url": "https://finance.yahoo.com/markets/stocks/articles/bittium-oyj-hlse-bitti-earnings-181044517.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:10:44+00:00", "published_display": "07 Aug 2026 18:10", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.099, "duplicate_count": 1, "topics": ["Balance Sheet", "Defense", "Earnings", "Earnings Growth", "Earnings Per Share", "Net Income"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 130, "call_budget": 500, "budget_used_pct": 26.0, "requests_made": 26, "last_success_at": "2026-08-13T03:01:46.711570+00:00", "newest_seen_at": "2026-08-13T02:28:06+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3681, "unmapped_mentions": 1792}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 59, "raw_score": 70, "total": 2, "evidence_count": 2, "effective_articles": 1.89, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 17, "confidence": 46, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-07T18:22:00+00:00", "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.2, "count": 2}], "positive_events": 1, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 130, "call_budget": 500, "budget_used_pct": 26.0, "requests_made": 26, "last_success_at": "2026-08-13T03:01:46.711570+00:00", "newest_seen_at": "2026-08-13T02:28:06+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3681, "unmapped_mentions": 1792}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 53.0, "latest_week": "2026-08-07", "one_week_move": 4.3, "four_week_move": 12.8, "twelve_week_move": 54.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.564351, "market_dynamics_buy_signal": false, "relative_strength": 34.046734, "fair_value_gap": 108.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 57.273, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.3% over one week, +12.8% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "News confirmed by price", "tone": "positive", "classification": "confirmed_positive", "summary": "Constructive news tone is being confirmed by positive weekly price action.", "confidence": 57, "badges": ["Sentiment confirms active trend", "Positive but stretched"], "opportunities": ["Constructive tone aligns with the Sharemaestro trend signal."], "risks": ["Constructive tone is arriving with price materially above fair value."], "event_label": "Earnings", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Evidence confidence", "value": "46/100", "tone": "neutral", "text": "1.89 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "News confirmed by price", "tone": "positive", "text": "Constructive news tone is being confirmed by positive weekly price action."}, {"label": "Primary event", "value": "Earnings", "tone": "positive", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "17/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+4.3% over one week, +12.8% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong"}], "updated_at": "2026-08-13T03:04:14.345819+00:00", "detail_intelligence": {"headline": "News confirmed by price", "summary": "Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 59, "display": "59", "tone": "positive", "note": "Constructive news tone"}, {"label": "Evidence confidence", "value": 46, "display": "46", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 83, "display": "83", "tone": "positive", "note": "17/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 24, "note": "1.89 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 40, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 83, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 40, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 2, "score": 70, "tone": "positive", "x": 683.2, "y": 98.6, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 866.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "683.2,98.6", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": 70, "delta": null, "recent_count": 0, "prior_count": 2, "volume_delta": -2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 2, "share": 100}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 70, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 2, "share": 100, "score": 70, "tone": "positive"}], "topics": [{"label": "Earnings", "count": 2, "share": 100}, {"label": "Pharma", "count": 1, "share": 50}, {"label": "Net Income", "count": 1, "share": 50}, {"label": "Fourth Quarter", "count": 1, "share": 50}, {"label": "Fda Approval", "count": 1, "share": 50}, {"label": "Earnings Per Share", "count": 1, "share": 50}, {"label": "Earnings Growth", "count": 1, "share": 50}, {"label": "Defense", "count": 1, "share": 50}, {"label": "Clinical Trials", "count": 1, "share": 50}, {"label": "Biotech", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to MOH."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 83/100, indicating a comparatively coherent tape."}, {"label": "Price response", "text": "Constructive news tone is being confirmed by positive weekly price action."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong", "summary": "Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind", "url": "https://finance.yahoo.com/healthcare/articles/cytk-q2-earnings-top-estimates-182200106.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:22:00+00:00", "published_display": "07 Aug 2026 18:22", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.061, "duplicate_count": 1, "topics": ["Biotech", "Clinical Trials", "Earnings", "Fda Approval", "Fourth Quarter", "Pharma"]}, "article_count": 2, "updated_at": "2026-08-13T01:47:55.637321+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 187.9, "label": "13 Feb 2026", "close": 35.52, "index": 100.0}, {"x": 77.5, "y": 191.8, "label": "20 Feb 2026", "close": 35.0, "index": 98.5}, {"x": 113.1, "y": 179.1, "label": "27 Feb 2026", "close": 36.68, "index": 103.3}, {"x": 148.6, "y": 179.0, "label": "06 Mar 2026", "close": 36.7, "index": 103.3}, {"x": 184.2, "y": 172.2, "label": "13 Mar 2026", "close": 37.6, "index": 105.9}, {"x": 219.7, "y": 160.7, "label": "20 Mar 2026", "close": 39.12, "index": 110.1}, {"x": 255.2, "y": 175.1, "label": "27 Mar 2026", "close": 37.22, "index": 104.8}, {"x": 290.8, "y": 162.4, "label": "03 Apr 2026", "close": 38.9, "index": 109.5}, {"x": 326.3, "y": 165.7, "label": "10 Apr 2026", "close": 38.46, "index": 108.3}, {"x": 361.8, "y": 180.4, "label": "17 Apr 2026", "close": 36.52, "index": 102.8}, {"x": 397.4, "y": 202.6, "label": "24 Apr 2026", "close": 33.58, "index": 94.5}, {"x": 432.9, "y": 179.6, "label": "01 May 2026", "close": 36.62, "index": 103.1}, {"x": 468.5, "y": 192.7, "label": "08 May 2026", "close": 34.89, "index": 98.2}, {"x": 504.0, "y": 197.3, "label": "15 May 2026", "close": 34.27, "index": 96.5}, {"x": 539.5, "y": 204.2, "label": "22 May 2026", "close": 33.37, "index": 93.9}, {"x": 575.1, "y": 187.0, "label": "29 May 2026", "close": 35.64, "index": 100.3}, {"x": 610.6, "y": 165.4, "label": "05 Jun 2026", "close": 38.49, "index": 108.4}, {"x": 646.2, "y": 165.9, "label": "12 Jun 2026", "close": 38.43, "index": 108.2}, {"x": 681.7, "y": 179.6, "label": "19 Jun 2026", "close": 36.62, "index": 103.1}, {"x": 717.2, "y": 168.1, "label": "26 Jun 2026", "close": 38.14, "index": 107.4}, {"x": 752.8, "y": 143.5, "label": "03 Jul 2026", "close": 41.4, "index": 116.6}, {"x": 788.3, "y": 101.2, "label": "10 Jul 2026", "close": 47.0, "index": 132.3}, {"x": 823.8, "y": 101.2, "label": "17 Jul 2026", "close": 47.0, "index": 132.3}, {"x": 859.4, "y": 74.7, "label": "24 Jul 2026", "close": 50.5, "index": 142.2}, {"x": 894.9, "y": 72.4, "label": "31 Jul 2026", "close": 50.8, "index": 143.0}, {"x": 930.5, "y": 55.8, "label": "07 Aug 2026", "close": 53.0, "index": 149.2}], "sentiment_points": [{"x": 689.7, "y": 126.3, "label": "20 Jun 2026", "score": 52}, {"x": 692.5, "y": 124.5, "label": "21 Jun 2026", "score": 53}, {"x": 697.5, "y": 122.6, "label": "22 Jun 2026", "score": 54}, {"x": 699.5, "y": 119.0, "label": "22 Jun 2026", "score": 56}, {"x": 699.8, "y": 119.0, "label": "22 Jun 2026", "score": 56}, {"x": 700.7, "y": 119.0, "label": "22 Jun 2026", "score": 56}, {"x": 705.5, "y": 117.1, "label": "23 Jun 2026", "score": 57}, {"x": 709.3, "y": 128.2, "label": "24 Jun 2026", "score": 51}, {"x": 717.9, "y": 131.8, "label": "26 Jun 2026", "score": 49}, {"x": 725.1, "y": 131.8, "label": "27 Jun 2026", "score": 49}, {"x": 742.3, "y": 130.0, "label": "30 Jun 2026", "score": 50}, {"x": 746.3, "y": 130.0, "label": "01 Jul 2026", "score": 50}, {"x": 748.3, "y": 130.0, "label": "02 Jul 2026", "score": 50}, {"x": 758.4, "y": 130.0, "label": "04 Jul 2026", "score": 50}, {"x": 762.2, "y": 130.0, "label": "04 Jul 2026", "score": 50}, {"x": 769.6, "y": 130.0, "label": "06 Jul 2026", "score": 50}, {"x": 778.7, "y": 130.0, "label": "08 Jul 2026", "score": 50}, {"x": 791.9, "y": 130.0, "label": "10 Jul 2026", "score": 50}, {"x": 797.6, "y": 130.0, "label": "11 Jul 2026", "score": 50}, {"x": 831.7, "y": 130.0, "label": "18 Jul 2026", "score": 50}, {"x": 834.2, "y": 130.0, "label": "19 Jul 2026", "score": 50}, {"x": 846.4, "y": 120.8, "label": "21 Jul 2026", "score": 55}, {"x": 856.1, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 856.6, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 857.1, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 857.2, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 877.0, "y": 119.0, "label": "27 Jul 2026", "score": 56}, {"x": 878.2, "y": 119.0, "label": "27 Jul 2026", "score": 56}, {"x": 884.4, "y": 109.8, "label": "28 Jul 2026", "score": 61}, {"x": 888.4, "y": 109.8, "label": "29 Jul 2026", "score": 61}, {"x": 889.0, "y": 100.6, "label": "29 Jul 2026", "score": 66}, {"x": 894.6, "y": 100.6, "label": "30 Jul 2026", "score": 66}, {"x": 897.9, "y": 100.6, "label": "31 Jul 2026", "score": 66}, {"x": 905.1, "y": 109.8, "label": "02 Aug 2026", "score": 61}, {"x": 909.0, "y": 115.3, "label": "02 Aug 2026", "score": 58}, {"x": 958.0, "y": 115.3, "label": "12 Aug 2026", "score": 58}], "price_path": "42.0,187.9 77.5,191.8 113.1,179.1 148.6,179.0 184.2,172.2 219.7,160.7 255.2,175.1 290.8,162.4 326.3,165.7 361.8,180.4 397.4,202.6 432.9,179.6 468.5,192.7 504.0,197.3 539.5,204.2 575.1,187.0 610.6,165.4 646.2,165.9 681.7,179.6 717.2,168.1 752.8,143.5 788.3,101.2 823.8,101.2 859.4,74.7 894.9,72.4 930.5,55.8", "sentiment_path": "689.7,126.3 692.5,124.5 697.5,122.6 699.5,119.0 699.8,119.0 700.7,119.0 705.5,117.1 709.3,128.2 717.9,131.8 725.1,131.8 742.3,130.0 746.3,130.0 748.3,130.0 758.4,130.0 762.2,130.0 769.6,130.0 778.7,130.0 791.9,130.0 797.6,130.0 831.7,130.0 834.2,130.0 846.4,120.8 856.1,126.3 856.6,126.3 857.1,126.3 857.2,126.3 877.0,119.0 878.2,119.0 884.4,109.8 888.4,109.8 889.0,100.6 894.6,100.6 897.9,100.6 905.1,109.8 909.0,115.3 958.0,115.3", "price_change": 49.2, "sentiment_change": 6, "latest_close": 53.0, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}